Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03177057
Other study ID # IRB12846
Secondary ID NCI-2015-02089IR
Status Completed
Phase N/A
First received
Last updated
Start date April 23, 2013
Est. completion date December 31, 2014

Study information

Verified date July 2018
Source Fox Chase Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best prevention plan and decrease national melanoma incidence and mortality.


Description:

PRIMARY OBJECTIVES:

I. To test the effects of a behavior tracking and individually-tailored daily text message intervention on sun protection and exposure behaviors and to see if these techniques will be most effective in conjunction or separately.

SECONDARY OBJECTIVES:

I. To examine mediators in the effects of the intervention on safe sun behaviors, based on Fishbein?s Integrative Model.

OUTLINE: Patients are randomized to 1 of 4 study arms.

ARM I (SELF-MONITORING): Patients complete tanning and sun protection usage entries daily for 14 days.

ARM II (TEXT MESSAGES): Patients receive individualized text messages based on baseline assessment of tanning motives (appearance, enjoyment, social) daily for 14 days.

ARM III (COMBINED GROUP): Patients complete tanning and sun protection usage entries and also receive individualized text messages daily for 14 days.

ARM IV (CONTROL GROUP): Patients complete study assessments.

After completion of study, patients are followed up at 2 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 114
Est. completion date December 31, 2014
Est. primary completion date July 30, 2014
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria:

- Women from the Philadelphia metropolitan area who own a mobile phone and who meet criteria for at least moderate risk of skin cancer based on a brief risk assessment tool

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Compliance Monitoring
Record behavior
Other:
Health Telemonitoring
Receive health monitoring text messages
Questionnaire Administration
Ancillary studies

Locations

Country Name City State
United States Fox Chase Cancer Center Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Fox Chase Cancer Center National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in ultraviolet radiation (UV) exposure and sun protection behaviors based on behavior tracking and individually tailored daily text messages Multiple variable regression models will be performed to examine the effect of the intervention on the outcomes. All post-baseline outcomes will be used as dependent variables. The baseline scores, intervention group, and time of the assessment will be included. To account for the within subject correlation of the responses, we will fit the model using Generalized Estimating Equations assuming an autoregressive working correlation matrix for each subject. Any p-value from the pairwise comparison that is less than 0.05 will be considered worthy of further study. Baseline to up to 2 weeks
Secondary Mediators and moderators of the intervention on behavior Mediation will be assessed by examining indirect effects, with bootstrapped confidence intervals to be calculated around the mediated effects. For participants who use the self-monitoring app, hierarchical linear modeling will be used to examine associations between tanning and sun protection as they occur daily, and motives for doing so. Using lagged multi-level models, the within-person model allows for assessment of individual change in behavior over the two-week time period, as well as the effect of each day?s behavior on behavior occurring on subsequent days. The between-person model allo At 2 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04358276 - Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study N/A
Completed NCT01242618 - Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule Phase 1
Not yet recruiting NCT06167096 - Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery N/A
Recruiting NCT03699995 - MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma N/A
Completed NCT04456140 - Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study Phase 1
Terminated NCT03630601 - Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers N/A
Recruiting NCT03543969 - Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma Early Phase 1
Completed NCT00783965 - Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back Phase 2
Recruiting NCT04475640 - Cancer Genetic Testing in Ethnic Populations N/A
Active, not recruiting NCT02465060 - Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Phase 2
Completed NCT02417948 - Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans N/A
Completed NCT03290989 - Itch and Pain Characteristics in Skin Carcinomas N/A